Related Posts
Worst consulting company to work for ?
Does Deloitte provide cab facility?
Chan Kitha❤️ Song is lit
35 F🐟, Boston, 🙋
Additional Posts in Life Sciences Consulting
How much do principals at IQVIA make?
does anyone here work for Veeva Crossix?
Anyone heard of Prescient Healthcare Group?
Has anyone heard of RegenXbio?
Which firms (if any) shut down for the holidays?
New to Fishbowl?
unlock all discussions on Fishbowl.



IQVIA
Generally use 59% / 41% if it’s a 2 drug market and no significant differentiation. A lot of papers published that will give you numbers around that.
Any resource links available?
Mentor
Best way to do it would be to identify an analogue situation. Eg a drug that’s been on market for a long/short time then a second class competitor comes in with a (un)differentiated profile. Then look at iqvia data to see how share was inpaxted
McKinsey put out a report on pharma market share based on order of entry some years back. Google and find this and you’ll have something reasonable to use/cite
Understand whether it’s targeting first / second / third line therapies is also important + then if multiple drugs already in that area, look at IQVIA / EvaluatePharma data to see how relative revenues / volumes changed on new drug entry